Long-term outcomes of graves disease in children treated with anti-thyroid drugs
Background: Graves disease (GD) is the most common cause of thyrotoxicosis in children and adolescents, accounting for 15% of all thyroid diseases during childhood. Anti-thyroid drugs (ATD) are recommended as the first-line treatment in children and adolescents. However, the remission rate is lower...
Main Authors: | Ya-Ting Chiang, Wei-Hsin Ting, Chi-Yu Huang, Shih-Kang Huang, Chon-In Chan, Bi-Wen Cheng, Chao-Hsu Lin, Yi-Lei Wu, Chen-Mei Hung, Hsin-Jung Li, Chia-Jung Chan, Yann-Jinn Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Pediatrics and Neonatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957219305595 |
Similar Items
-
The treatment of Graves' disease in children and adolescents
by: Hae Sang Lee, et al.
Published: (2014-09-01) -
Timing of Graves’ Hyperthyroidism Management in Pregnant Women: Impact on the Infant Thyroid Volume
by: Aleksandra Mikołajczak, et al.
Published: (2022-05-01) -
Indefinite antithyroid drug therapy in toxic Graves′ disease: What are the cons
by: Rajesh Rajput, et al.
Published: (2013-01-01) -
Thyroid‐stimulating hormone receptor antibodies during follow‐up as remission markers in childhood‐onset Graves' disease treated with antithyroid drugs
by: Shuo‐Yu Wang, et al.
Published: (2020-04-01) -
Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse
by: Tsz Wai Catherine Wong, et al.
Published: (2022-12-01)